
DermaPrecise
@dermaprecise
DermaPrecise is an electronic multi-needle dermal injector to be used when consistent precision over depth, dose, and delivery matters. Owned by @RepliCel.
ID: 1453761011459100678
https://www.replicel.com/products/rci-02 28-10-2021 16:30:34
15 Tweet
44 Followers
70 Following


د. نجلاء عبدالله الدوسري FDA In Brief: FDA Warns Public and Health Care Professionals Not to Use Needle-free Devices for Injection of Dermal Fillers fda.gov/news-events/pr…

We are very pleased to announce the name and trademark for the RepliCel Life Sciences Inc. dermal injector. DermaPrecise (tm) is an electronic multi-needle dermal injector to be used when consistent precision over depth, dose, and delivery matters. biospace.com/article/releas… via BioSpace


It's not a product launch (yet) but its a product and we are pleased to be launching the trademark to start building pre-market awareness for the #dermalinjector we've developed for use with injections where precision matters. finance.yahoo.com/news/replicel-… RepliCel Life Sciences Inc. Life Sciences BC





Another great injectible approved. This one (by LEO Pharma) for the treatment of the very painful atopic dermatitis. We are actively exploring the benefits of controlled, highly reproducible and precise, multi-needle dispersion for such treatment protocols.


As RepliCel Life Sciences Inc. said, we're excited to share our first dermal injector data showing consistent injection and distribution in donated skin tissue. When injection precision matters, we believe DermaPrecise will be the only and best solution for intra-dermal + sub-cutaneous injections


The RepliCel Life Sciences Inc. DermaPrecise Injector Shown to Produce Consistently High Cell Viability for Cell Therapy Injections. The Innovacell testing shows that DermaPrecise may greatly improve post-injection cell viability for injections into dermal or subcu tissue. accesswire.com/viewarticle.as…